Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | oxolinic acid | 3883 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | oxolinic acid | 3883 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | pargyline | 4688 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pargyline | 4688 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pargyline | 4688 | drug-path |
Glioma | Q9NZM4 | map05214 | STOCK1N-28457 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | STOCK1N-28457 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | STOCK1N-28457 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | STOCK1N-28457 | None | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | STOCK1N-28457 | None | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | STOCK1N-28457 | None | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | STOCK1N-28457 | None | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | STOCK1N-28457 | None | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | STOCK1N-28457 | None | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | STOCK1N-28457 | None | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | STOCK1N-28457 | None | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | STOCK1N-28457 | None | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | STOCK1N-28457 | None | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | STOCK1N-28457 | None | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | STOCK1N-28457 | None | drug-path |